physarumin

from myxomycete Physarum polycephalum; MW 22 kDa; calcium dependent agglutinating

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Sarcoma 180 03/01/1998 - "Physarumin agglutinated not only several species of erythrocytes but also tumor cells such as AH109A ascites hepatoma cells, sarcoma 180 ascites cells and mouse leukemia P388 cell lines. "
2.	Neoplasms (Cancer) 03/01/1998 - "Physarumin had tumor cell growth-inhibitory activity, and induced the apoptosis of P388 cell lines. " 03/01/1998 - "Physarumin agglutinated not only several species of erythrocytes but also tumor cells such as AH109A ascites hepatoma cells, sarcoma 180 ascites cells and mouse leukemia P388 cell lines. "
3.	Leukemia P388 03/01/1998 - "Physarumin agglutinated not only several species of erythrocytes but also tumor cells such as AH109A ascites hepatoma cells, sarcoma 180 ascites cells and mouse leukemia P388 cell lines. "
4.	Hepatocellular Carcinoma (Hepatoma) 03/01/1998 - "Physarumin agglutinated not only several species of erythrocytes but also tumor cells such as AH109A ascites hepatoma cells, sarcoma 180 ascites cells and mouse leukemia P388 cell lines. "
5.	Ascites 03/01/1998 - "Physarumin agglutinated not only several species of erythrocytes but also tumor cells such as AH109A ascites hepatoma cells, sarcoma 180 ascites cells and mouse leukemia P388 cell lines. "